AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 77 filers reported holding AKCEA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $313,000 | -10.1% | 17,228 | -32.2% | 0.01% | -17.6% |
| Q2 2020 | $348,000 | -14.3% | 25,409 | -10.4% | 0.02% | -52.8% |
| Q1 2020 | $406,000 | -48.4% | 28,364 | -38.9% | 0.04% | +2.9% |
| Q4 2019 | $787,000 | +20.5% | 46,433 | +9.4% | 0.04% | +59.1% |
| Q3 2019 | $653,000 | -9.2% | 42,460 | +38.4% | 0.02% | +10.0% |
| Q2 2019 | $719,000 | – | 30,670 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |